These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 203386)

  • 1. Role of arylhydroxamic acid acyltransferase in the mutagenicity of N-hydroxy-N-2-fluorenylacetamide in Salmonella typhimurium.
    Weeks CE; Allaben WT; Louie SC; Lazear EJ; King CM
    Cancer Res; 1978 Mar; 38(3):613-8. PubMed ID: 203386
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of structure of N-acyl-N-2-fluorenylhydroxylamines on arylhydroxamic acid acyltransferase, sulfotransferase, and deacylase activities, and on mutations in Salmonella typhimurium TA 1538.
    Weeks CE; Allaben WT; Tresp NM; Louie SC; Lazear EJ; King CM
    Cancer Res; 1980 Apr; 40(4):1204-11. PubMed ID: 6986982
    [No Abstract]   [Full Text] [Related]  

  • 3. Mechanism of in vitro mutagenic activation and covalent binding of N-hydroxy-2-acetylaminofluorene in isolated liver cell nuclei from rat and mouse.
    Sakai S; Reinhold CE; Wirth PJ; Thorgeirsson SS
    Cancer Res; 1978 Jul; 38(7):2058-67. PubMed ID: 26463
    [No Abstract]   [Full Text] [Related]  

  • 4. Activation of carcinogenic arylhydroxamic acids by human tissues.
    King CM; Olive CW; Cardona RA
    J Natl Cancer Inst; 1975 Aug; 55(2):285-7. PubMed ID: 1159819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sulfation in the metabolism and mutagenicity of N-hydroxy-2-fluorenylacetamide.
    Hinson JA; Andrews LS; Gillette JR
    Natl Cancer Inst Monogr; 1981 Dec; (58):113-6. PubMed ID: 6176868
    [No Abstract]   [Full Text] [Related]  

  • 6. Dietary lipid-dependent activation of the carcinogen N-2-fluorenylacetamide in rats as monitored by Salmonella typhimurium.
    Castro CE; Felkner IC; Yang SP
    Cancer Res; 1978 Sep; 38(9):2836-41. PubMed ID: 354780
    [No Abstract]   [Full Text] [Related]  

  • 7. Bacterial mutagenesis and host cell DNA damage by chemical carcinogens in the Salmonella/hepatocyte system.
    Staiano N; Erickson LC; Thorgeirsson SS
    Biochem Biophys Res Commun; 1980 Jun; 94(3):837-42. PubMed ID: 6994733
    [No Abstract]   [Full Text] [Related]  

  • 8. Mechanism of N-hydroxy-2-acetylaminofluorene mutagenicity in the Salmonella test system. Role of N-O acyltransferase and sulfotransferase from rat liver.
    Wirth PJ; Thorgeirsson SS
    Mol Pharmacol; 1981 Mar; 19(2):337-44. PubMed ID: 6939968
    [No Abstract]   [Full Text] [Related]  

  • 9. Mutagenic activation of N-hydroxy-2-acetylaminofluorene in the Salmonella test system: the role of deacetylation by liver and kidney fractions from mouse and rat.
    Schut HA; Wirth PJ; Thorgeirsson SS
    Mol Pharmacol; 1978 Jul; 14(4):682-92. PubMed ID: 683178
    [No Abstract]   [Full Text] [Related]  

  • 10. Metabolic activation of arylhydroxamic acids by N-O-acyltransferase of rat mammary gland.
    King CM; Traub NR; Lortz ZM; Thissen MR
    Cancer Res; 1979 Sep; 39(9):3369-72. PubMed ID: 476668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The relationship of 2-acetamidofluorene mutagenicity in plate tests with its in vivo liver cell component distribution and its carcinogenic potential.
    McGregor D
    Mutat Res; 1975 Dec; 30(3):305-15. PubMed ID: 1105163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alteration of the ability of liver microsomes to activate N-2-fluorenylacetamide to a mutagen of Salmonella typhimurium during hepatocarcinogenesis.
    Stout DL; Becker FF
    Cancer Res; 1978 Aug; 38(8):2274-8. PubMed ID: 208764
    [No Abstract]   [Full Text] [Related]  

  • 13. Rat mammary gland carcinogenesis after local injection of N-hydroxy-N-acyl-2-aminofluorenes: relationship to metabolic activation.
    Allaben WT; Weeks CE; Weis CC; Burger GT; King CM
    Carcinogenesis; 1982; 3(3):233-40. PubMed ID: 7083466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative electrophilicity, mutagenicity, DNA repair induction activity, and carcinogenicity of some N- and O-acyl derivatives of N-hydroxy-2-aminoflourene.
    Bartsch H; Malaveille C; Stich HF; Miller EC; Miller JA
    Cancer Res; 1977 May; 37(5):1461-7. PubMed ID: 322856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Species difference in liver microsomal and cytosolic enzymes involved in mutagenic activation of N-hydroxy-N-2-fluorenylacetamide.
    Kaneda S; Seno T; Takeishi K
    J Natl Cancer Inst; 1981 Sep; 67(3):549-55. PubMed ID: 6944527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition by diacylmethane derivatives of mutagenicity and nucleic acid binding of 2-aminofluorene derivatives.
    Wang CY; Lee MS; Nagase H; Zukowski K
    J Natl Cancer Inst; 1989 Nov; 81(22):1743-7. PubMed ID: 2681797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitory effect of reducing agents on N-acetoxy- and N-hydroxy-2-acetylaminofluorene-induced mutagenesis.
    Rosin MP; Stich HF
    Cancer Res; 1978 May; 38(5):1307-10. PubMed ID: 346207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence for a second arylhydroxamic acid acyltransferase species in the small intestine of the rat.
    Olive CW; King CM
    Chem Biol Interact; 1975 Dec; 11(6):599-604. PubMed ID: 1201619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of N-hydroxyphenacetin to mutagenic and nucleic acid-binding metabolites by acyltransfer, deacylation, and sulfate conjugation.
    Vaught JB; McGarvey PB; Lee MS; Garner CD; Wang CY; Linsmaier-Bednar EM; King CM
    Cancer Res; 1981 Sep; 41(9 Pt 1):3424-9. PubMed ID: 7020926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of conjugation reactions on the mutagenicity of aromatic amines.
    Hongslo J; Haug LT; Wirth PJ; Møller M; Dybing E; Thorgeirsson SS
    Mutat Res; 1983 Feb; 107(2):239-47. PubMed ID: 6346076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.